Short-term Treatment with a Low Dose of Inhaled Fluticasone Propionate Decreases the Number of CD1a+ Dendritic Cells in Asthmatic Airways

Author： Bocchino V.   Bertorelli G.   Zhuo X.   Grima P.   Di Comite V.   Damia R.   Chetta A.   del Donno M.   Foresi A.   Casalini A.   Testi R.   Olivieri D.  

Publisher： Academic Press

ISSN： 1094-5539

Source： Pulmonary Pharmacology & Therapeutics, Vol.10, Iss.5, 1997-05, pp. : 253-259

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Short-Term Safety and Tolerability of Double-Dose Salmeterol/Fluticasone Propionate in Adult Asthmatic Patients

By Adolfsson Lars-Erik  

Clinical Drug Investigation, Vol. 25, Iss. 4, 2005-01 ,pp. : 231-241

Adis International

Access to resources Recommend Favorite

Fluticasone propionate: a potent inhaled corticosteroid for the treatment of asthma

By Staresinic A.G.   Sorkness C.A.  

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 6, 2000-09 ,pp. : 1227-1244

Informa Healthcare

Access to resources Recommend Favorite

Cost Effectiveness of Inhaled Fluticasone Propionate vs Inhaled Triamcinolone Acetonide in the Treatment of Persistent Asthma

By Stanford R.H.  

Clinical Drug Investigation, Vol. 20, Iss. 4, 2000-10 ,pp. : 237-244

Adis International

Access to resources Recommend Favorite

Inhaled fluticasone propionate suppresses adrenal function

By  

Inpharma, Vol. 1, Iss. 1331, 2002-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

Fluticasone propionate for asthma: dose-response relationship

By  

Inpharma, Vol. 1, Iss. 1300, 2001-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite